Product Reports Resources Pricing Login Book a demo

DxCover

Biotech & Life Sciences · Glasgow, United Kingdom · Founded 2016

Developing a spectroscopic liquid biopsy for rapid detection of cancer MoreLess

DxCover is a clinical-stage liquid biopsy company that has developed the PANAROMIC™ platform for early detection of multiple cancers. The company's technology, known as Multi-Omic Spectral Analysis (MOSA-Dx), analyzes the biochemical profile of a patient's blood serum using infrared spectroscopy and artificial intelligence to identify the presence or absence of disease.

DxCover's platform is designed to provide rapid, cost-effective, and non-invasive cancer diagnostics. The company is currently conducting clinical trials for the detection of brain, colorectal, and lung cancers. By detecting cancers at an earlier stage, DxCover aims to improve patient outcomes and reduce healthcare costs. The company's business model is focused on the development and commercialization of its diagnostic tests for use in clinical settings, such as hospitals and laboratories.

Keywords: liquid biopsy, cancer diagnostics, early detection, artificial intelligence, spectroscopy, multi-omic, PANAROMIC, MOSA-Dx, clinical trials, non-invasive

Company overview

DxCover company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2016
Headquarters
Glasgow, United Kingdom
Employees
30
Open positions
None listed
Dealroom signal
72.0
client focusb2btechnologyArtificial IntelligencetechnologyDeep TechtechnologyRecognition Technologysub industryBioTechnologysub industryMedical Devicessub industryHealth Platformbusiness modelManufacturingindustryHealthsectorBiotechnologysectorOncologysectorNeurologysectorCore AIsectorHealth Diagnostics

Valuation & funding

DxCover funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCEquity / VC Feb 2025 $6.6M $50M SIS Ventures · University of Strathclyde · Eos Advisory · Norcliffe Capital
SERIES AEquity / VC Feb 2023 $9.9M $40M SIS Ventures · Mark Bamforth · Eos Advisory · Scottish Enterprise Growth Investments
SEEDEquity / VC Mar 2021 $1.5M $16M Norcliffe Capital · Eos Advisory · Strathclyde University Incubator
SEEDEquity / VC Sep 2020 $3.2M $13M Eos Advisory · SIS Ventures · Scottish Enterprise Growth Investments · Mercia Asset Management
SUPPORT PROGRAMOther financing Sep 2019 $0 Tech Nation
SEEDEquity / VC May 2019 Scottish Enterprise Growth Investments · Mercia Asset Management
GRANTOther financing Feb 2019 Scottish EDGE
SPINOUTOther financing Jan 2016 University of Strathclyde
Showing 8 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 30
2025 32
2024 24
2023 21
2022 19
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

DxCover website traffic

Latest recorded traffic for DxCover is 820 monthly website visits, down 75.9% over the last three months. DxCover's team declined 6.3% over the past year.

Latest monthly visits820 3-month web change-75.9% 1-year team growth-6.3%
Monthly website visits70 observations · Nov 2018–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

DxCover compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

DxCover's talent

Book a demo to see the people
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

15 investors on DxCover's cap table

Sourced from Dealroom's funding and investor records.

Seed 7 investors entered at this stage
Scottish EDGE
Scottish Enterprise Growth Investments
Mercia Asset Management
Eos Advisory
SIS Ventures
Norcliffe Capital
Strathclyde University Incubator
Series A 4 investors entered at this stage
Mark Bamforth
University of Strathclyde
Maven Capital Partners
Macmillan Cancer Support
Other known 4 additional known investors
Tech Nation
Alba Equity
Investing Women
Mercia Ventures

Global footprint

Where DxCover has talent and traffic

Workforce by country
2 countries with
team presence
🇬🇧 United Kingdom80%
🇺🇸 United States20%
2 countries shown

In the news

Latest news about DxCover

Recent press, funding announcements, and product moves mentioning DxCover — open to read from the original sources.

See all news

Market sentiment

What the market is saying about DxCover

An AI-synthesized read of the highest-engagement posts about DxCover on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See DxCover’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.